Asher Marks

1.3k total citations · 1 hit paper
37 papers, 795 citations indexed

About

Asher Marks is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Asher Marks has authored 37 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 13 papers in Pulmonary and Respiratory Medicine and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Asher Marks's work include Glioma Diagnosis and Treatment (14 papers), Childhood Cancer Survivors' Quality of Life (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Asher Marks is often cited by papers focused on Glioma Diagnosis and Treatment (14 papers), Childhood Cancer Survivors' Quality of Life (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Asher Marks collaborates with scholars based in United States, Germany and Israel. Asher Marks's co-authors include Edward A. Gaensler, Whitney W. Addington, Charles B. Carrington, Irving M. Madoff, Anne M. Goff, Jules R. Schwaber, John B. Cadigan, David W. Cugell, Robert H. Jones and Michael L. DiLuna and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Asher Marks

33 papers receiving 692 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chronic Eosinophilic Pneumonia

1969 353 citations Asher Marks, Edward A. Gaensler et al. profile →

Peers

Countries citing papers authored by Asher Marks

Since Specialization

Citations

This map shows the geographic impact of Asher Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asher Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asher Marks more than expected).

Fields of papers citing papers by Asher Marks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asher Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asher Marks. The network helps show where Asher Marks may publish in the future.

Co-authorship network of co-authors of Asher Marks

This figure shows the co-authorship network connecting the top 25 collaborators of Asher Marks. A scholar is included among the top collaborators of Asher Marks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asher Marks. Asher Marks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	“Techquity” in Pediatric, Adolescent, and Young Adult Oncology: Addressing Inequities Through Artificial Intelligence and Immersive Technologies 2025 ·Pediatric Blood & Cancer ·(unknown), (unknown), Asher Marks	0
2	Applying principles to practice: cleaning and disinfection of extended reality equipment used in healthcare settings 2025 ·Infection Control and Hospital Epidemiology ·Thomas S. Murray, Erica S. Shenoy, Scott C. Roberts, Richard A. Martinello, Asher Marks, Kimberly Hieftje, (unknown), (unknown), (unknown), (unknown), (unknown), Shannon Novosad, Janet Glowicz	0
3	Barriers to Effective Infection Prevention in the Neonatal Intensive Care Unit 2024 ·Advances in Neonatal Care ·(unknown), Abigail Crocker, Thomas S. Murray, (unknown), (unknown), (unknown), Asher Marks, Richard A. Martinello, Kimberly Hieftje	1
4	Loss to follow‐up of minorities, adolescents, and young adults on clinical trials: A report from the Children's Oncology Group 2023 ·Cancer ·(unknown), Lingyun Ji, Xinxin Xu, Michael Roth, David R. Freyer, A. Lindsay Frazier, Asher Marks, Farzana Pashankar	13
5	The importance of escalating molecular diagnostics in patients with low-grade pediatric brain cancer 2023 ·Molecular Case Studies ·(unknown), Gunes Gundem, Benjamin Liechty, Andrea Sboner, Juan S. Medina-Martínez, Elli Papaemmanuil, Cora N. Sternberg, Asher Marks, Mark M. Souweidane, Jeffrey P. Greenfield, Ivy Tran, Matija Snuderl, Olivier Elemento, Marcin Imieliński, David J. Pisapia, Juan Miguel Mosquera	2
6	Use of Immersive Virtual Reality Spaces to Engage Adolescent and Young Adult Patients With Cancer in Therapist-Guided Support Groups: Protocol for a Pre-Post Study 2023 ·JMIR Research Protocols ·Asher Marks, (unknown), Kimberly Hieftje, (unknown), (unknown), (unknown)	4
7	Personality Changes and Staring Spells in a 12-Year-Old Child: A Case Report Incorporating ChatGPT, a Natural Language Processing Tool Driven by Artificial Intelligence (AI) 2023 ·Cureus ·(unknown), (unknown), Michael L. DiLuna, Kimberly Hieftje, Asher Marks	12
8	Spectrum of qualitative and quantitative imaging of pilomyxoid, intermediate pilomyxoid and pilocytic astrocytomas in relation to their genetic alterations 2022 ·Neuroradiology ·(unknown), (unknown), (unknown), (unknown), Asher Marks, Nicolas Linder, Karl‐Titus Hoffmann, Armine Darbinyan, Anita Hüttner, Mariam Aboian	1
9	Disinfection of Virtual Reality Devices in Health Care Settings: In Vitro Assessment and Survey Study 2022 ·Journal of Medical Internet Research ·Scott C. Roberts, (unknown), (unknown), (unknown), (unknown), Richard Feinn, (unknown), Richard A. Martinello, Asher Marks, Thomas S. Murray	8
10	Topographic correlates of driver mutations and endogenous gene expression in pediatric diffuse midline gliomas and hemispheric high-grade gliomas 2021 ·Scientific Reports ·(unknown), Asher Marks, Jin Cui, Armine Darbinyan, Elizabeth Tong, Sabine Mueller, Soonmee Cha, Mariam Aboian	2
11	Dual activating FGFR1 mutations in pediatric pilomyxoid astrocytoma 2021 ·Molecular Genetics & Genomic Medicine ·Elena I. Fomchenko, Benjamin C. Reeves, William Sullivan, Asher Marks, Anita Hüttner, Kristopher T. Kahle, E. Zeynep Erson‐Omay	3
12	Clinical Application of Digital Technologies in Adolescent and Young Adult Oncology Supportive Care 2020 ·Journal of Adolescent and Young Adult Oncology ·(unknown), Asher Marks	5
13	Persistent STAG2 mutation despite multimodal therapy in recurrent pediatric glioblastoma 2020 ·npj Genomic Medicine ·Christopher S. Hong, Juan C. Vasquez, Adam J. Kundishora, Aladine A. Elsamadicy, Jason M. Beckta, Amrita Sule, Asher Marks, Nalin Leelatian, Anita Hüttner, Ranjit S. Bindra, Michael L. DiLuna, Kristopher T. Kahle, E. Zeynep Erson‐Omay	4
14	Carbon Monoxide Diffusing Capacity During Steady Exercise1,2,3. Comparison of Physiologic and Histologic Findings in Patients with Pulmonary Fibroses and Granulomatoses 2019 ·David W. Cugell, Asher Marks, (unknown), (unknown), Edward A. Gaensler	0
15	The coexistence of lupus erythematosus panniculitis and subcutaneous panniculitis-like T-cell lymphoma in the same patient 2018 ·JAAD Case Reports ·Xinyu Wu, Antonio Subtil, Brittany G. Craiglow, Kalman L. Watsky, Asher Marks, Christine J. Ko	8
16	Low-Grade Astrocytoma within a Mature Cystic Teratoma in an Adolescent Patient 2017 ·Journal of Pediatric and Adolescent Gynecology ·(unknown), Asher Marks, Pei Hui, Babak Litkouhi, (unknown)	5
17	SOX2 immunity and tissue resident memory in children and young adults with glioma 2017 ·Journal of Neuro-Oncology ·Juan C. Vasquez, Anita Hüttner, Lin Zhang, Asher Marks, (unknown), Joachim M. Baehring, Kristopher T. Kahle, Kavita M. Dhodapkar	28
18	Adjuvant Radiation Therapy Patterns and Survival Implications for Medulloblastoma in Young Children 2016 ·International Journal of Radiation OncologyBiologyPhysics ·Benjamin H. Kann, (unknown), N.H. Lester-Coll, D.N. Yeboa, (unknown), Ranjit S. Bindra, (unknown), Asher Marks, Kenneth B. Roberts	1
19	Primary spinal myxopapillary ependymoma in the pediatric population: a study from the Surveillance, Epidemiology, and End Results (SEER) database 2016 ·Journal of Neuro-Oncology ·(unknown), (unknown), Kristopher T. Kahle, Asher Marks, Michael L. DiLuna	17
20	A Review of Secondary Central Nervous System Tumors After Treatment of a Primary Pediatric Malignancy 2012 ·Seminars in Pediatric Neurology ·Asher Marks, Roger J. Packer	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact